Plaque Psoriasis

Oral Glucocorticoids for Psoriasis? The Expert Weighs In
Glucocorticoids
by Allison Sit on
Dermatologists are prescribing oral glucocorticoids for psoriasis despite awareness of risks of life-threatening generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP). A recent survey of dermatologists published in the Journal of Drugs in Dermatology found 18% of respondents occasionally prescribe oral glucocorticoids to patients with psoriasis, typically 1-5% of the time. Those wh …
Pediatric Scaling Diseases: An Approach to Pediatric Psoriasis
Pediatric Psoriasis
by Jacqueline McKesey, MD, MS on
Dr. Lawrence F. Eichenfield, meeting co-chair for the 17th Annual Women’s and Pediatric Dermatology Seminar, kicked off session III with a superb talk titled “Scaling the Heights…and Below, Pediatric Scaling Diseases: Psoriasis and Others”,  giving us a bird’s eye view on the old and the new regarding pediatric psoriasis. Dr. Eichenfield is a complete rock star and served as a valued …
Histocompatibility Antigen – Friday Pop Quiz 1/14
by NEXT STEPS IN DERM TEAM on
A 23-year-old female presents with itchy and irritated rash in the image. The rash began in her late teens. She has a family history of similar rash in her mother. Which histocompatibility antigen is most likely in this patient? A. HLA-Cw2 B. HLA-Cw6 C. HLA-B51 D. HLA-B27 E. HLA-Bw35 To find out the correct answer and read the explanation, click here.    Brought to yo …
Acitretin for Psoriasis | Therapeutic Cheat Sheet
acitretin
by Azam Qureshi, MD on
Pustular psoriasis can present quickly and pose a life-threatening emergency. Acitretin is the only systemic retinoid FDA-approved for treatment of psoriasis, specifically both pustular and severe plaque-type psoriasis.1Systemic retinoids such as acitretin are utilized heavily in dermatology, and practitioners must be knowledgeable about all of the FDA-approved and off-label applications as well a …
Special Focus on Acne and Rosacea
Acne and Rosacea
by NEXT STEPS IN DERM TEAM on
The June issue of the Journal of Drugs in Dermatology focuses on the topics of acne and rosacea, and features additional articles on topics such as atopic dermatitis and psoriasis. Straight from the JDD Editor’s desk, we share this month’s issue highlights: Guest Editor James Q. Del Rosso discusses roadblocks that impede patient ability to obtain medications selected by their dermatologist …